Biotech Values

[DewDiligence]

BioCurex Update

[I wonder if BioCurex has considered merging with VasoActive.]

http://biz.yahoo.com/pz/040630/60118.html

>>
VANCOUVER, British Columbia, June 30, 2004 (PRIMEZONE) -- BioCurex Inc. (Other OTC:BOCX.PK) wishes to advise its shareholders that the Company is moving forward in its process to re-establish quotation on the OTC:BB. BioCurex has been diligent in its commitment to this process and shares the frustration of many investors who have indicated astonishment that we have had to undergo this lengthy administrative course. We appreciate the support we have received and are confident that our investors' patience will be rewarded with further corporate advances. [How eloquent!]

The Company also wants to reassure its shareholders that it continues to move effectively in the scientific and business arenas and anticipates further updates in the near term. BioCurex is strongly committed to its RECAF technology which has demonstrated a very significant and consistent ability to detect many types of cancer. We are confident in our direction and capability to introduce our diagnostic tests to the world markets.
<<